Chronic Kidney Disease News

PHILADELPHIA — A study into Medicare beneficiaries with stage 3-5 chronic kidney disease suggests that an additional term should be used to describe a subset of patients with class 3 disease, according to data presented at ASN Kidney Week.

AWAK Technologies has received a breakthrough device designation from the FDA for its progression prediction model directed at patients with chronic kidney disease, according to a press release.

PHILADELPHIA — A speaker unveiled the American Heart Association’s new PREVENT equations to evaluate 10- and 30-year absolute risk associated with cardiovascular-kidney-metabolic syndrome.

PHILADELPHIA — Researchers from Alpine Immune Sciences Inc. presented clinical findings using povetacicept to treat autoimmune glomerulonephritis during ASN Kidney Week.

PHILADELPHIA — The case of a 29-year-old woman with chronic kidney disease presented at ASN Kidney Week highlighted the need for better health care education to help patients understand the risks and consequences of their disease.

PHILADELPHIA — Sparsentan was shown to be safe and well-tolerated, and reduced proteinuria in adults with IgA nephropathy, according to studies presented at ASN Kidney Week.

PHILADELPHIA — An analysis of patients with chronic kidney disease showed a high prevalence of treatment-resistant hypertension, emphasizing the need for better management of the condition, according to a presentation at ASN Kidney Week.

PHILADELPHIA — Treating hyperkalemia with Lokelma (sodium polystyrene sulfonate, AstraZeneca) increased odds of patients maintaining renin-angiotensin-aldosterone system inhibitors therapy, a speaker said.

PHILADELPHIA — Remdesivir did not reduce adverse cardiovascular or kidney events in adults with underlying kidney damage hospitalized for COVID-19, a speaker here said.

PHILADELPHIA — Percutaneous kidney biopsy is a feasible and safe procedure when testing patients with small kidneys, according to the results of a study presented at ASN Kidney Week.